Brazil · Delayed Price · Currency is BRL CME Group Statistics
Total Valuation
CME Group has a market cap or net worth of BRL 582.48 billion. The enterprise value is 578.34 billion.
| Market Cap | 582.48B |
| Enterprise Value | 578.34B |
Important Dates
The next confirmed earnings date is Wednesday, April 22, 2026.
| Earnings Date | Apr 22, 2026 |
| Ex-Dividend Date | Mar 9, 2026 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.10% |
| Shares Change (QoQ) | -0.05% |
| Owned by Insiders (%) | 0.30% |
| Owned by Institutions (%) | 92.21% |
| Float | 357.01M |
Valuation Ratios
The trailing PE ratio is 26.30 and the forward PE ratio is 25.56.
| PE Ratio | 26.30 |
| Forward PE | 25.56 |
| PS Ratio | 16.25 |
| PB Ratio | 3.68 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 25.22 |
| P/OCF Ratio | 24.73 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.94, with an EV/FCF ratio of 25.04.
| EV / Earnings | 26.11 |
| EV / Sales | 16.82 |
| EV / EBITDA | 21.94 |
| EV / EBIT | 23.63 |
| EV / FCF | 25.04 |
Financial Position
The company has a current ratio of 1.03, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.03 |
| Quick Ratio | 0.03 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.81 |
| Debt / FCF | 0.90 |
| Interest Coverage | 24.56 |
Financial Efficiency
Return on equity (ROE) is 14.75% and return on invested capital (ROIC) is 11.35%.
| Return on Equity (ROE) | 14.75% |
| Return on Assets (ROA) | 1.59% |
| Return on Invested Capital (ROIC) | 11.35% |
| Return on Capital Employed (ROCE) | 11.17% |
| Weighted Average Cost of Capital (WACC) | 5.61% |
| Revenue Per Employee | 9.25M |
| Profits Per Employee | 5.72M |
| Employee Count | 3,875 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CME Group has paid 6.93 billion in taxes.
| Income Tax | 6.93B |
| Effective Tax Rate | 23.61% |
Stock Price Statistics
The stock price has increased by +7.75% in the last 52 weeks. The beta is 0.26, so CME Group's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | +7.75% |
| 50-Day Moving Average | 387.46 |
| 200-Day Moving Average | 351.09 |
| Relative Strength Index (RSI) | 53.77 |
| Average Volume (20 Days) | 9 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.29 |
Income Statement
In the last 12 months, CME Group had revenue of BRL 35.84 billion and earned 22.15 billion in profits. Earnings per share was 61.47.
| Revenue | 35.84B |
| Gross Profit | 35.84B |
| Operating Income | 23.46B |
| Pretax Income | 29.36B |
| Net Income | 22.15B |
| EBITDA | 25.28B |
| EBIT | 23.46B |
| Earnings Per Share (EPS) | 61.47 |
Balance Sheet
The company has 25.02 billion in cash and 20.69 billion in debt, with a net cash position of 4.32 billion.
| Cash & Cash Equivalents | 25.02B |
| Total Debt | 20.69B |
| Net Cash | 4.32B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 158.23B |
| Book Value Per Share | 440.82 |
| Working Capital | 27.88B |
Cash Flow
In the last 12 months, operating cash flow was 23.56 billion and capital expenditures -459.92 million, giving a free cash flow of 23.10 billion.
| Operating Cash Flow | 23.56B |
| Capital Expenditures | -459.92M |
| Depreciation & Amortization | 1.76B |
| Net Borrowing | -49.95M |
| Free Cash Flow | 23.10B |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of 65.46% and 62.58%.
| Gross Margin | 100.00% |
| Operating Margin | 65.46% |
| Pretax Margin | 81.92% |
| Profit Margin | 62.58% |
| EBITDA Margin | 70.54% |
| EBIT Margin | 65.46% |
| FCF Margin | 64.45% |
Dividends & Yields
This stock pays an annual dividend of 9.95, which amounts to a dividend yield of 2.47%.
| Dividend Per Share | 9.95 |
| Dividend Yield | 2.47% |
| Dividend Growth (YoY) | -5.13% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 96.58% |
| Buyback Yield | -0.10% |
| Shareholder Yield | 2.37% |
| Earnings Yield | 3.80% |
| FCF Yield | 3.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
CME Group has an Altman Z-Score of 0.52 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.52 |
| Piotroski F-Score | 5 |